Merck & Co., Inc.

MRK Health Care · Pharmaceuticals & Biotechnology

Latest period 2026-06-30 · 39 filings on record

Quarterly TTM Annual

8Q 3Y 5Y 10Y MAX

23-09 → 26-06 12 QUARTERS

SHOWING Discrete quarters as filed — each point is one 10-Q, or a Q4 derived from the 10-K.

Ranked against Health Care · 51 peers

Each grade is a single reported quarter's assessment, never an average — a card shows the grade at the newest quarter in view, so it follows the period and range controls above. Latest scored quarter: 2026-06-30.

Growth 17th pct

▼−52 over range · as of 2026-06-30

Revenue +5.1% YoY, earnings -130.2% YoY · sector avg 66

Quality 29th pct

▼−28 over range · as of 2026-06-30

-8.0% net margin, 8% return on equity, 24% free-cash-flow margin, profitable in 6 of last 8 quarters · sector avg 45

Safety 38th pct

▼−1 over range · as of 2026-06-30

1.3x current ratio · sector avg 65

OVERVIEWQoQ Δ

Latest quarter · ending 2026-06-30 · green = improving · click a row to chart it

Revenue $16.6B +2.0% CHARTED Gross margin 73.5% −0.7pp Operating margin — — Net margin -8.0% +18.0pp Net income -$1.3B —

Debt / equity 1.28 +20.1%

EPS (diluted) -$0.54 — EBITDA — —

Filings

23-09 → 26-06 · following the period bar 13 match

ALL 10-K 10-Q Q1 Q2 Q3 FY SORT NEWEST ↓

Filings by fiscal year and period
Year	Q1	Q2	Q3	FY
2026	10-Q Q1 2026	10-Q Q2 2026	no filing	no filing
2025	10-Q Q1 2025	10-Q Q2 2025	10-Q Q3 2025	10-K FY 2025
2024	10-Q Q1 2024	10-Q Q2 2024	10-Q Q3 2024	10-K FY 2024
2023	no filing	no filing	10-Q Q3 2023	10-K FY 2023

10-Q Q2 2026 2026-08-07 Pro → 10-Q Q1 2026 2026-05-04 Pro → 10-K FY 2025 2026-02-24 Pro → 10-Q Q3 2025 2025-11-05 Pro → 10-Q Q2 2025 2025-08-05 Pro → 10-Q Q1 2025 2025-05-02 Pro →

All 13 filings

10-K FY 2024 2025-02-25 Pro → 10-Q Q3 2024 2024-11-06 Pro → 10-Q Q2 2024 2024-08-05 Pro → 10-Q Q1 2024 2024-05-03 Pro → 10-K/A FY 2024-04-11 Pro → 10-K FY 2023 2024-02-26 Pro → 10-Q Q3 2023 2023-11-03 Pro →

Filing-level fact detail is a Pro feature. The grades and figures above are free. See Pro plans

Trends

Quarter-over-quarter, from cached filings

Revenue

Latest$16.6B QoQ+2.0% Periods12

Revenue by period
Period	Period end	Revenue
23-09	2023-09-30	$16.0B
23-12	2023-12-31	$14.6B
24-03	2024-03-31	$15.8B
24-06	2024-06-30	$16.1B
24-09	2024-09-30	$16.7B
24-12	2024-12-31	$15.6B
25-03	2025-03-31	$15.5B
25-06	2025-06-30	$15.8B
25-09	2025-09-30	$17.3B
25-12	2025-12-31	$16.4B
26-03	2026-03-31	$16.3B
26-06	2026-06-30	$16.6B

Net income

Latest-$1.3B QoQ— Periods12

Net income by period
Period	Period end	Net income
23-09	2023-09-30	$4.7B
23-12	2023-12-31	-$1.2B
24-03	2024-03-31	$4.8B
24-06	2024-06-30	$5.5B
24-09	2024-09-30	$3.2B
24-12	2024-12-31	$3.7B
25-03	2025-03-31	$5.1B
25-06	2025-06-30	$4.4B
25-09	2025-09-30	$5.8B
25-12	2025-12-31	$3.0B
26-03	2026-03-31	-$4.2B
26-06	2026-06-30	-$1.3B

ZOOM

18-09 26-06

Grade history

Point-in-time: each period shows the grade of the quarter it ends at — grades are never summed or averaged across a window.

Growth 17 Quality 29 Safety 38

Hover to read every grade at a period · shared with the trends chart · axis fixed 0–100

Grade history by period
Period	Period end	Growth	Quality	Safety
23-09	2023-09-30	68	57	39
23-12	2023-12-31	27	19	33
24-03	2024-03-31	77	49	30
24-06	2024-06-30	79	64	48
24-09	2024-09-30	30	60	41
24-12	2024-12-31	73	64	46
25-03	2025-03-31	36	69	43
25-06	2025-06-30	12	69	50
25-09	2025-09-30	57	64	55
25-12	2025-12-31	21	71	48
26-03	2026-03-31	15	38	34
26-06	2026-06-30	17	29	38